Dow Logs Triple-Digit Surge After FDA Approves First Covid-19 Vaccine

Indexes kicked off the week with a win, boosted mostly by reopening stocks and news that the U.S. Food and Drug Administration (FDA) officially approved the first Covid-19 vaccine. Specifically, the Dow tacked on 215 points, after the FDA approved Pfizer's (PFE) coronavirus vaccine, which the company developed with BioNTech (BNTX). The S&P 500 closed comfortably in the black, boosted by a surge in energy stocks, while the Nasdaq nabbed a new record close. Looking ahead, investors are awaiting this week's annual Jackson Hole symposium, with regards to the latest on monetary policy.

The Dow Jones Average (DJI - 35,335.71) added 215.6 points or 0.6% for the day. Boeing (BA) paced the long list of Dow winners today, rising 3.2%, while UnitedHealth fell 1%, bottoming out the list.

The S&P 500 Index (SPX - 4,479.53) rose 37.9 points or 0.9% for the day. Meanwhile, the Nasdaq Composite (IXIC - 14,942.65) gained 228 points, or 1.6%, for the day.

Lastly, the Cboe Volatility Index (VIX - 17.15) fell 1.4 points or 7.6%, for the day.

closing summary 0823

UVOL 0823

nyse nasdaq 0823

OIL SNAPS LONGEST LOSING STREAK SINCE 2019

Today, oil snapped its longest losing streak since 2019. The positive price action came after the U.S. dollar retreated, and investors brushed aside the recent selling. As a result, October-dated crude futures tacked on $3.50, or 5.6%, to settle at $65.64 per barrel.

Gold prices also popped today, with the precious metal rising above the key $1,800 level thanks to the dented dollar. In addition, bullion's appeal was bolstered by expectations that the U.S. Federal Reserve may put a hold on the tapering of economic support as coronavirus cases rise. December-dated gold added $22.30, or 1.3%, to settle at $1,806.30 an ounce today.

Disclaimer: Copyright © 2021 S&P Dow Jones Indices LLC, a division of S&P Global. All rights reserved. This material is reproduced with the prior written consent of S&P DJI. Please ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments